Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 22, 2015 7:16 AM ET

Healthcare Equipment and Supplies

Company Overview of Capnia, Inc.

Company Overview

Capnia, Inc. develops diagnostics and therapeutics based on its proprietary technology for precision metering of gas flow primarily in the United States. The company offers CoSense for the diagnosis of excessive hemolysis in neonates, a condition that causes long-term developmental disability due to the degradation of red blood cells. It also develops Serenz, a therapeutic product candidate that has completed phase II clinical trials for the treatment of symptoms related to allergic rhinitis. The company was founded in 1999 and is headquartered in Redwood City, California.

3 Twin Dolphin Drive

Suite 160

Redwood City, CA 94065

United States

Founded in 1999

15 Employees





Key Executives for Capnia, Inc.

Chief Executive Officer, President and Director
Age: 46
Total Annual Compensation: $433.1K
Chief Financial Officer and Principal Accounting Officer
Age: 55
Total Annual Compensation: $121.2K
Vice President of Research and Development
Age: 52
Total Annual Compensation: $246.8K
Compensation as of Fiscal Year 2014.

Capnia, Inc. Key Developments

Capnia, Inc. expected to report Fiscal Year 2014 results on May 22, 2015. This event was calculated by Capital IQ (Created on May 16, 2015).

Capnia, Inc. expected to report Fiscal Year 2014 results on May 22, 2015. This event was calculated by Capital IQ (Created on May 16, 2015).

Capnia, Inc. Announces Unaudited Earnings Results for the Quarter Ended March 31, 2015

Capnia, Inc. announced unaudited earnings results for the quarter ended March 31, 2015. or the quarter, the company announced revenue of $22,000. Operating loss was $2,426,000 compared to $684,000 for the same period a year ago. Net loss was $11,651,000 compared to $834,000 for the same period a year ago. Basic and diluted net loss per common share was $1.67 compared to $1.56 for the same period a year ago.

Capnia, Inc. Appoints Edward Ebbers as Chief Commercial Officer

Capnia, Inc. announced the appointment of Edward Ebbers as Chief Commercial Officer, effective April 13, 2015. Mr. Ebbers will be responsible for Capnia's commercial organization, including managing the ongoing commercial rollout of the company's product, CoSense®. Prior to joining Capnia, Mr. Ebbers served as Vice President, Worldwide Marketing, Ophthalmology Products at Clarity Medical Systems.

Similar Private Companies By Industry

Company Name Region
Neurowave Medical Technologies LLC United States
Carwild Corporation United States
Windstone Medical Packaging, Inc. United States
Advanced Refractive Technologies Inc. United States
Medex Medical, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Capnia, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at